返回 Agenda
SLS04 Scientific Benefit-Risk Management and Communication for the Future
Session Chair(s)
Mamoru Narukawa, PhD, RPh
Professor, Kitasato University, Japan
Speaker(s)
Gerald Dal Pan, MD, MHS
Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Juan Garcia-Burgos, MD, PhD
Head of Public and Stakeholders Engagement Department, European Medicines Agency, Netherlands
Kazuhiko Ishida, MSc, RPh
Director, Pharmacovigilance, Astellas Pharma Inc., Japan